JFrog Ltd. FROG 深 沪
等待开盘 02-03 09:30:00 美东时间
55.52
+0.720
+1.31%
华盛通- 最 高56.61
- 今 开54.89
- 成交量 149.94万股
- 最 低 53.96
- 昨 收 54.80
- 总市值 65.51亿
- 52周最高 70.4299
- 市盈率 静 --
- 换手率 1.27%
- 52周最低 27.00
- 委 比 14.29%
- 总股本 1.18亿
- 历史最高 95.20
- 量 比 0.79
- 振 幅 4.84%
- 历史最低 16.356
- 每 手 1
- 风险率 10.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JFrog CTO Yoav Landman Reports Sale of Common Shares
JFrog CTO Yoav Landman Reports Sale of Common Shares Yoav Landman, Chief Technology Officer and Director of JFrog Ltd., has reported a disposal of common shares of JFrog Ltd. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT)
01-22 05:15
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Barclays Maintains Overweight on JFrog, Raises Price Target to $70
Barclays analyst Ryan Macwilliams maintains JFrog (NASDAQ:FROG) with a Overweight and raises the price target from $67 to $70.
01-13 04:03
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Piper Sandler Maintains Neutral on JFrog, Raises Price Target to $70
Piper Sandler analyst Rob Owens maintains JFrog (NASDAQ:FROG) with a Neutral and raises the price target from $60 to $70.
01-06 00:47
Security Tech Check-In: Analyst Insights From 12 Companies Ahead Of The 'Quiet Period'
Needham analysts met with 12 companies before quiet period. Ratings and price targets by analyst Mike Cikos.
2025-12-19 03:38
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
